We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YELL
3226
DELISTED
Yellow Corporation Common Stock
YELL
$47K ﹤0.01%
9,330
-8,949
-49% -$49.1K
ADCT icon
3227
ADC Therapeutics
ADCT
$130M
$46K ﹤0.01%
9,473
+8,773
+1,253% +$63.5K
AXIA
3228
DELISTED
AXIA Energia
AXIA
$46K ﹤0.01%
7,279
+5,986
+463% +$41.5K
FLNT
3229
Fluent
FLNT
$131M
$46K ﹤0.01%
5,681
-1,161
-17% -$9.83K
GEL icon
3230
Genesis Energy
GEL
$1.94B
$46K ﹤0.01%
+5,005
New +$50.9K
IGMS
3231
DELISTED
IGM Biosciences
IGMS
$46K ﹤0.01%
2,019
-2,833
-58% -$57.2K
IMAX icon
3232
IMAX
IMAX
$2.9B
$46K ﹤0.01%
3,260
+2,029
+165% +$32.6K
IMUX icon
3233
Immunic
IMUX
$221M
$46K ﹤0.01%
1,469
+614
+72% +$25.7K
LXRX icon
3234
Lexicon Pharmaceuticals
LXRX
$1.03B
$46K ﹤0.01%
19,389
+13,232
+215% +$36.6K
MBI icon
3235
MBIA
MBI
$261M
$46K ﹤0.01%
4,914
+976
+25% +$11.6K
KG
3236
Kestrel Group
KG
$61M
$46K ﹤0.01%
1,081
-72
-6% -$3.06K
MIRM icon
3237
Mirum Pharmaceuticals
MIRM
$6.12B
$46K ﹤0.01%
2,210
-593
-21% -$14.3K
MNKD icon
3238
MannKind Corp
MNKD
$1.23B
$46K ﹤0.01%
14,921
-14,199
-49% -$53.5K
MYPS icon
3239
PLAYSTUDIOS Inc
MYPS
$64M
$46K ﹤0.01%
13,016
+1,572
+14% +$5.99K
PBYI icon
3240
Puma Biotechnology
PBYI
$449M
$46K ﹤0.01%
19,360
+1,427
+8% +$4.17K
PDBC icon
3241
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.65B
$46K ﹤0.01%
2,836
-688
-20% -$11.8K
PNTG icon
3242
Pennant Group
PNTG
$1.36B
$46K ﹤0.01%
4,464
+3,056
+217% +$43.7K
RLYB icon
3243
Rallybio
RLYB
$89.5M
$46K ﹤0.01%
397
+154
+63% +$13.7K
RBCP
3244
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
$46K ﹤0.01%
441
-69
-14% -$7.86K
RPT
3245
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$46K ﹤0.01%
6,075
-48,436
-89% -$476K
RTL
3246
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$46K ﹤0.01%
7,755
+3,697
+91% +$27.3K
SHLX
3247
DELISTED
Shell Midstream Partners, L.P.
SHLX
$46K ﹤0.01%
+2,948
New +$45.6K
CASS icon
3248
Cass Information Systems
CASS
$747M
$45K ﹤0.01%
1,300
+628
+93% +$22.5K
CLSK icon
3249
CleanSpark
CLSK
$3.12B
$45K ﹤0.01%
14,190
+12,163
+600% +$52.6K
CMPS
3250
Compass Pathways
CMPS
$1.83B
$45K ﹤0.01%
4,190
-705
-14% -$10.6K
128 129
130
131 132

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.